Castlight Health Inc issued its financial guidance for 2018 and its results for the fourth quarter and full year 2017.

It expects to see a non-GAAP net loss per share of approximately 11 cents to 15 cents and a non-GAAP operating loss in the range of $15 million to $20 million. The company projected GAAP revenue between $150 million and $155 million.

The consensus normalized EPS estimate for 2018 is a net loss of 13 cents, according to S&P Capital IQ.

Castlight Health reported a net loss of $8.6 million, or a net loss of 6 cents per share, in the fourth quarter of 2017, a slight improvement from a net loss of $9.1 million, or a net loss of 9 cents, in the previous-year period.

Non-GAAP net loss was $5.7 million, or a net loss of 4 cents per share, in the last three months of 2017, compared to a net loss of $1.4 million, or a net loss of 1 cent per share, in the prior-year quarter.

The S&P Capital IQ consensus normalized EPS estimate for the fourth quarter of 2017 was a net loss of 5 cents.

For full year 2017, the company had a non-GAAP net loss of $27.3 million, or a net loss of 22 cents per share, compared to a net loss of $30.2 million, or a net loss of 30 cents per share, in 2016.

The consensus normalized EPS estimate for 2017 was a net loss of 23 cents, according to S&P Capital IQ.